Jamie Chorlton

COO at SonoTarg Ltd

Presenter

Jamie is Chief Operating Officer at SonoTarg, where he is responsible for the clinical development of SonoTarg’s lead product ST-001. With 30 years’ experience in drug development, Jamie brings significant phase I-III clinical trial experience to the SonoTarg team, especially in the fields of oncology and immunology. Prior to joining SonoTarg, Jamie was Head of Clinical Development at St George Street Capital, a UK based charity focussed on the repurposing of deprioritised pharma assets. Jamie has also served in C-level positions in several Clinical Research Organisations, including as CEO of Altair Clinical. Jamie holds a BSc (Hons) degree in Biomedical Technology.